$1.97
5.98% yesterday
NYSE, Nov 15, 10:09 pm CET
ISIN
US35168W1036
Symbol
GUTS
Sector
Industry

Fractyl Health Stock price

$1.97
-0.41 17.09% 1M
-5.19 72.52% 6M
-13.04 86.90% YTD
-13.04 86.90% 1Y
-13.04 86.90% 3Y
-13.04 86.90% 5Y
-13.04 86.90% 10Y
NYSE, Closing price Fri, Nov 15 2024
-0.13 5.98%
ISIN
US35168W1036
Symbol
GUTS
Sector
Industry

Key metrics

Market capitalization $94.18m
Enterprise Value $72.45m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 724.50
P/S ratio (TTM) P/S ratio 941.80
P/B ratio (TTM) P/B ratio 1.88
Revenue (TTM) Revenue $100.00k
EBIT (operating result TTM) EBIT $-81.30m
Free Cash Flow (TTM) Free Cash Flow $-60.75m
Cash position $84.66m
EPS (TTM) EPS $-6.16
P/E forward negative
P/S forward 2,003.40
EV/Sales forward 1,568.80
Short interest 7.16%
Show more

Is Fractyl Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Fractyl Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Fractyl Health forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Fractyl Health forecast:

Buy
100%

Financial data from Fractyl Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
0.10 0.10
-
100%
- Direct Costs 0.54 0.54
-
540%
-0.45 -0.45
-
-450%
- Selling and Administrative Expenses 20 20
-
20,010%
- Research and Development Expense 60 60
-
60,360%
-81 -81
-
-80,810%
- Depreciation and Amortization 0.49 0.49
-
490%
EBIT (Operating Income) EBIT -81 -81
-
-81,302%
Net Profit -63 -63
-
-62,900%

In millions USD.

Don't miss a Thing! We will send you all news about Fractyl Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fractyl Health Stock News

Neutral
Seeking Alpha
about 22 hours ago
Fractyl Health, Inc. (NASDAQ:GUTS ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Stephen Jasper - Gilmartin Group Harith Rajagopalan - Co-Founder and CEO Lisa Davidson - CFO Conference Call Participants Michael Ulz - Morgan Stanley Michael DiFiore - Evercore ISI William Wood - B. Riley Securities Operator Good afternoon, and welcome to Fractyl Health's Thir...
Neutral
GlobeNewsWire
3 days ago
REMAIN-1 weight maintenance pivotal study enrollment progressing rapidly; mid-point data analysis expected in Q2 2025 Anticipate reporting data from REVEAL-1 open-label cohort beginning in Q4 2024 Topline data from REVITALIZE-1 pivotal study expected in mid-2025 Company presented compelling weight maintenance data from both Revita ® and Rejuva ® platforms at ObesityWeek ® 2024 Conference call t...
Neutral
GlobeNewsWire
11 days ago
13-week follow-up represents the longest data to-date demonstrating durable efficacy of RJVA-001 on weight and blood sugar in the diet-induced obesity (DIO) mouse model
More Fractyl Health News

Company Profile

Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.

Head office United States
CEO Harith Rajagopalan
Founded 2010
Website www.fractyl.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today